New Bullseye for Cancer Treatment: A Gene Called KRAS

Wall Street Journal by Jacob Goldstein | May. 30, 2008 (News Report)

a growing body of evidence suggests that cancers with the standard form of this gene respond better to an important class of cancer drugs than tumors with a common mutation of the gene. Full Story »

Posted by Beth Wellington

More Info

Tags Help
Subjects: Business, Sci/Tech, Health
Topics: Pharmaceuticals, Biology, Cancer
Editorial Help
Posted by: Posted by Beth Wellington - May 31, 2008 - 9:54 AM PDT
Reviewed by: Beth Wellington (review)
Edit Lock: This story can be edited

Reviews

Show All Comments
Show All | Notes | Comments | Quotes | Links
Beth Wellington
3.5
 by Beth Wellington - Oct. 1, 2008
Beth posted this story.
See Full Review » (1 answer)

Comments on this story Help (BETA)

Sort by: Oldest | Newest Hide All Replies
NT Rating | My Rating

Ratings

3.4

not enough reviews
from 1 review (10% confidence)
Popularity
3.4
Recommendation
4.0
# Reviews
1.0
# Views
5.0
# Likes
1.0
# Emails
1.0
More
How our ratings work »
(See these related stories.)

Links Help

No links yet. Please review this story to add some!